ZAP-x

MediJourn, in partnership with Apollo Hospitals, is transforming brain tumor treatment with ZAP-X, a revolutionary technology offering quick, non-invasive sessions. Apollo Hospitals, a leader in healthcare for over 40 years, has introduced ZAP-X to provide pain-free treatment with minimal radiation exposure. This innovative approach underscores Apollo’s commitment to advancing healthcare through cutting-edge solutions, making them the first center in South Asia to offer this groundbreaking treatment option.  

The advantages of ZAP-X over traditional brain surgery are manifold:

1. Enhanced Precision: ZAP-X precisely targets the affected area, eliminating the need to expose the entire region as required in traditional methods such as craniotomy.
2. Non-invasive Treatment: ZAP-X delivers highly focused radiation directly to the lesion, bypassing the need for skull opening as in traditional surgical approaches.
3. Shortened Treatment Duration: While traditional brain surgeries typically last 3-4 hours, ZAP-X completes treatment in a single session lasting no more than 30 minutes.

Daycare Convenience: ZAP-X allows for a daycare procedure, enabling patients to return home post-treatment, unlike traditional surgeries that necessitate 4-7 days or more of hospitalization and anesthesia. This feature offers a more convenient and patient-friendly treatment experience.

ZAP-X is highly effective in addressing the following conditions:

1. Benign Intracranial Tumors: This includes acoustic neuroma, pituitary adenomas, and meningiomas.
2. Brain Metastasis: ZAP-X treats tumors that have spread to the brain from other parts of the body.
3. Arteriovenous Malformations (Cerebral AVM): ZAP-X resolves disruptions in blood flow caused by tangled blood vessels.
4. Trigeminal Neuralgia: ZAP-X provides relief from severe facial pain associated with nerve disorders.
5. Select Recurrent High-Grade Gliomas: ZAP-X offers tailored treatment for specific cases of aggressive brain tumors.